Polychromatic erythrocytes

Mouse bone marrow polychromatic-erythrocyte assay (micronucleus test) Micronuclei B Usha Rani et al. 1980... 

Polycyclic Aromatic Hydrocarbon Physiologically Based Pharmacodynamic Physiologically Based Pharmacokinetic polychromatic erythrocytes permissible exposure limit photo ionization detector picogram picomole... 

There was no increase in the incidence of micronucleated normochromatic erythrocytes or polychromatic erythrocytes in the peripheral blood of male and female mice exposed to 1,000, 4,000, or 10,000 ppm... 

Micronucleus test To evaluate the clastogenic activity in mice using polychromatic erythrocytes... 

Ciranni et al. (1988) found no evidence of fetal cellular toxicity, as measured by a reduction in the polychromatic erythrocyte/normochromatic erythrocyte... 

The in vivo micronucleus test is used for the detection of damage to chromosomes as well as the mitotic apparatus in bone marrow or peripheral blood cells of rodents. The assay system has been well standardized.14-17 The basic features of the test system are (1) the effect of the test chemical is observed in anucleated polychromatic erythrocytes (PCEs) (2) PCEs have a relatively short lifespan, so that any micronuclei they contain must have been generated as a result of recently induced chromosome damage (3) micronuclei are readily identifiable and their distribution is well defined and (4) the frequency of induced micronuclei in PCEs is dependent on sampling times. 

Genotoxic effects have been reported in animals treated with 3,3 -dichlorobenzidine. A single dose of 3,3 -dichlorobenzidine (1,000 mg/kg) administered to male and pregnant female mice induced micronuclei in polychromatic erythrocytes in the bone marrow of the males and in the liver of the fetuses, but not in bone marrow of the dams (Cihak and Vontorkova 1987). A micronucleus test is performed to detect a chemical s ability to induce chromosomal aberrations. However, the relevance of micronuclei formation to human health is not known. The reason for the lack of effect of 3,3 -dichlorobenzidine on bone marrow micronuclei formation in the mothers is unclear, but it may be related to deficiencies in the metabolic activation of 3,3 -dichlorobenzidine in female mice. The relative importance of pregnancy is unknown since the study did not evaluate nonpregnant females. In another study, an increase in unscheduled deoxyribonucleic acid synthesis (UDS) was observed in cultured liver cells from male mice previously pretreated orally with single doses of 500 mg/kg 3,3 -dichlorobenzidine no response was observed at a dose of 200 mg/kg (Ashby and Mohammed 1988). 

Animals, usually rodents, are exposed to the test substance by an appropriate route, usually by gavage or by intraperitoneal injection. Each treated and control group must include at least five animals per sex. Positive controls should produce micronuclei in vivo at exposure levels expected to give a detectable increase over background. No standard treatment schedule (i.e., 1, 2, or more treatments at 24-h intervals) has been recommended. Three dose levels are generally used these should cover a range from the maximum to little or no toxicity. The erythrocytes are sampled from the bone marrow and/or peripheral blood of the animals. If bone marrow is used, the animals are sacrificed at appropriate times after treatment, the bone marrow extracted, and preparations made and stained. When peripheral blood is used, the blood is collected at appropriate times after treatment and smear preparations are made and stained. Preparations are analyzed for the presence of micronuclei. An increase in the frequency of micronucleated polychromatic erythrocytes in treated animals is an indication of induced chromosome damage. 

The test is used for the detection of cytogenetic damage to the chromosomes or the mitotic apparatus of erythroblasts by analysis of erythrocytes for formation of micronuclei (small nuclei, separate from and additional to the main nuclei of cells, produced during the telophase of mitosis (meiosis) by lagging chromosome fragments or whole chromosomes). When a bone marrow erythroblast develops into a polychromatic erythrocyte (immature erythrocyte), the main nucleus is extruded any micronucleus that has been formed may remain behind in the otherwise anucleated cytoplasm. 

Studies in several test systems have shown DCB to be genotoxic in vitro and in vivo and suggest that this effect most likely mediates the carcinogenicity of the chemical. In vitro, DCB has induced sister chromatid exchanges, unscheduled DNA synthesis, and positive responses in bacterial Salmonella assays in vivo DCB induced micronuclei in polychromatic erythrocytes in male mice and fetuses. ... 

Genotoxicity inhibition. Hot water extract of the fmit, administered intragastrically to mice at a dose of 500 mg/kg, was active vs adriamycin-, cyclophosphamine-, procarha-zine-, and mitomycin-induced genotoxicity. Genotoxicity was measured hy the presence of micronucleated polychromatic erythrocytes in bone marrow... 

---